Publication | Open Access

Expression of B7 co-stimulatory molecules by B16 melanoma results in a natural killer cell-dependent local anti-tumour response, but induces T-cell-dependent systemic immunity only against B7-expressing tumours

B7 Co-stimulatory MoleculesCancer ImmunosurveillanceImmunologyTumor ImmunityB7-expressing TumoursImmunologic MechanismAutoimmunityImmune Checkpoint InhibitorB16 Melanoma ResultsImmunotherapyMedicineCell BiologyTumor Microenvironment